Global WholeHealth Partners Corp, (OTC:GWHP) a multinational medical diagnostics supplier of over 70+ products with 56 already FDA approved and several approved for export only including Dengue, Ebola, Zika, Malaria and also offering one of the largest lines of tests for CoViD19 SARS2, announces that they are pioneers of the only biodegradable plant based plastic for medical devices after receiving provisional patent. As the Biden administration announced on Monday a big push to make rapid COVID-19 home tests available with a $230 million federal contract through the Department of Defense, Global WholeHealth Partners Corp. (OTC:GWHP) CEO, Charles Strongo, said, “We understand the growth needed in the in-vitro diagnostic segment and the need for more rapid tests, and at the same time we understand that there is also a need to GO GREEN.” “We took that challenge and created a proper mix of plant based material which is 100% biodegradable, to make a plastic that is biodegradable to help the medical industry,” said Mr. Strongo.   Global WholeHealth Partners acknowledges the fact that tens of millions of plastic medical devices are used every month in the US alone and hundreds of millions throughout the world. Just in the US alone, Healthcare   Read more…